<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04722328</url>
  </required_header>
  <id_info>
    <org_study_id>04 CNS infection</org_study_id>
    <nct_id>NCT04722328</nct_id>
  </id_info>
  <brief_title>Establishment of Prevention and Control System of Central Nervous System Infection</brief_title>
  <official_title>Establishment of Prevention and Control System of Central Nervous System Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xuanwu Hospital, Beijing</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Central nervous system (CNS) infection is a common nervous system acute and severe disease,&#xD;
      mainly manifested as encephalitis, meningitis and meningoencephalitis, but also manifested as&#xD;
      brain abscess and brain granuloma et al. The basis for the diagnosis of CNS infection lies in&#xD;
      the detection of pathogens from brain parenchyma or cerebellar spinal fluid (CSF). However,&#xD;
      CSF is relatively difficult to obtain and the sample size is small, which limits the rapid&#xD;
      and definite diagnosis of CNS infection pathogens. In addition, CNS infection usually has&#xD;
      non-specific clinical manifestations, so it is difficult to identify the pathogen for about&#xD;
      half of CNS infection. Metagenomic next generation sequencing (mNGS) and biochip technology&#xD;
      provide new means to identify the pathogens of CNS infection. This study analyzes the&#xD;
      incidence and epidemic characteristics of CNS infection in China, to standardize the CSF&#xD;
      sample processing process, shorten the detection time, increase the sensitivity and&#xD;
      specificity of pathogen detection, reduce the detection cost, identify the common pathogens&#xD;
      of CNS infection, and establish a standardized rapid diagnosis system, effective prevention&#xD;
      and control system.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificity of pathogen detection</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>I Identify the common pathogens of CNS infection</measure>
    <time_frame>3 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">715</enrollment>
  <condition>Central Nervous System (CNS) Infection</condition>
  <condition>Encephalitis</condition>
  <condition>Meningitis</condition>
  <arm_group>
    <arm_group_label>CNS infection</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-CNS infection</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CSF metagenomic next generation sequencing (mNGS)</intervention_name>
    <description>TestCSF routine, biochemical, smear staining (Gram staining, acid fast staining, ink staining), culture and mNGSã€‚</description>
    <arm_group_label>CNS infection</arm_group_label>
    <arm_group_label>Non-CNS infection</arm_group_label>
    <other_name>CSF detection: routine, biochemical, smear staining (Gram staining, acid fast staining, ink staining), culture.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Criteria for clinical suspected encephalitis: acute or subacute onset, fever before and&#xD;
        after the onset, symptoms and signs of brain parenchyma damage, including generalized or&#xD;
        focal epilepsy (not related to previous epilepsy), mental and behavioral abnormalities,&#xD;
        newly emerging local neurological deficit, disturbance of consciousness, etc.&#xD;
&#xD;
        Clinical suspected meningitis criteria: acute or subacute onset, with fever, headache,&#xD;
        vomiting, disturbance of consciousness and meningeal irritation as the main clinical&#xD;
        manifestations, accompanied by cranial nerve and brain parenchyma damage.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical suspected encephalitis or meningitis; onset time within 1 month; modified&#xD;
             Rankin Scale (MRS) &lt; 2 points before onset; informed consent of patients; patients who&#xD;
             can not express their personal wishes due to aphasia, disturbance of consciousness and&#xD;
             other reasons need to obtain the informed consent of their authorized relatives.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yingfeng Wu</last_name>
    <role>Study Chair</role>
    <affiliation>Xuanwu Hospital, Beijing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yan Zhang, Phd</last_name>
    <phone>0086-13671376710</phone>
    <email>zhangylq@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xuanwu Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2021</study_first_posted>
  <last_update_submitted>January 19, 2021</last_update_submitted>
  <last_update_submitted_qc>January 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Central nervous system (CNS) infection</keyword>
  <keyword>diagnosis</keyword>
  <keyword>pathogen</keyword>
  <keyword>Metagenomic next generation sequencing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Central Nervous System Infections</mesh_term>
    <mesh_term>Meningitis</mesh_term>
    <mesh_term>Encephalitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The number, age, gender, diagnosis and outcome of the cases.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

